Table 2.
Participant baseline characteristics
| Characteristic | IDeg | IDet |
|---|---|---|
| Full analysis set (FAS), n | 174 | 176 |
| 1–5 | 43 | 42 |
| 6–11 | 70 | 68 |
| 12–17 | 61 | 66 |
| Female/Male (%) | 44.8/55.2 | 44.3/55.7 |
| 1–5 | 46.5/53.5 | 59.5/40.5 |
| 6–11 | 42.9/57.1 | 39.7/60.3 |
| 12–17 | 45.9/54.1 | 39.4/60.6 |
| Race: White/Black/Asian/Other (%) | 78.2/2.9/13.2/5.7 | 71.0/2.8/18.2/8.0 |
| 1–5 | 86.0/2.3/2.3/9.3 | 78.6/2.4/9.5/9.5 |
| 6–11 | 77.1/1.4/14.3/7.2 | 72.1/1.5/17.6/8.8 |
| 12–17 | 73.8/4.9/19.7/1.6 | 65.2/4.5/24.2/6.0 |
| Ethnicity: Hispanic or Latin American (%) | 4.0 | 1.7 |
| 1–5 | 9.3 | 2.4 |
| 6–11 | 4.3 | 2.9 |
| 12–17 | 0 | 0 |
| Age (yr) | 10.0 (±4.4) | 10.0 (±4.4) |
| 1–5 | 4.3 (±1.1) | 4.1 (±1.1) |
| 6–11 | 9.3 (±1.7) | 9.2 (±1.7) |
| 12–17 | 14.8 (±1.7) | 14.6 (±1.8) |
| Weight (kg) | 38.0 (±18.7) | 37.8 (±18.9) |
| 1–5 | 18.0 (±4.0) | 17.8 (±3.8) |
| 6–11 | 32.9 (±7.7) | 31.4 (±8.1) |
| 12–17 | 57.9 (±14.5) | 57.2 (±14.2) |
| BMI (kg/m2) | 18.7 (±3.6) | 18.5 (±3.6) |
| 1–5 | 16.2 (±1.7) | 16.3 (±1.7) |
| 6–11 | 17.7 (±2.6) | 17.1 (±2.3) |
| 12–17 | 21.6 (±3.8) | 21.5 (±3.6) |
| Duration of diabetes (yr) | 3.9 (±3.6) | 4.0 (±3.4) |
| 1–5 | 1.4 (±1.0) | 1.4 (±1.0) |
| 6–11 | 3.2 (±2.4) | 3.9 (±2.4) |
| 12–17 | 6.4 (±4.3) | 5.7 (±4.2) |
| HbA1c (%) | 8.2 (±1.1) | 8.0 (±1.1) |
| 1–5 | 8.1 (±1.2) | 8.0 (±1.3) |
| 6–11 | 8.1 (±1.0) | 8.1 (±1.0) |
| 12–17 | 8.3 (±1.1) | 8.0 (±1.1) |
| HbA1c (mmol/mol*) | 66.1 | 63.9 |
| 1–5 | 65.0 | 63.9 |
| 6–11 | 65.0 | 65.0 |
| 12–17 | 67.2 | 63.9 |
| FPG, mmol/L [mg/dL] | 9.0 (±5.2) [162.1 (±94.4)] | 8.4 (±4.9) [151.0 (±87.7)] |
| 1–5 | 9.3 (±6.0) [167.5 (±107.6)] | 9.2 (±5.2) [166.0 (±93.5)] |
| 6–11 | 9.3 (±4.1) [166.8 (±74.3)] | 8.2 (±5.0) [147.6 (±89.4)] |
| 12–17 | 8.5 (±5.8) [153.5 (±105.1)] | 8.1 (±4.6) [145.1 (±82.5)] |
*
Calculated value.
Data are mean (SD) unless otherwise stated.